Rhonda Cooper-DeHoff, PharmD, MS, FAHA, FACC, FCCP

Associate Professor & Associate Director, Center for Pharmacogenomics and Precision Medicine

University of Florida, Gainesville

Rhonda M. Cooper-DeHoff, Pharm.D., M.S., FCCP, FACC, FAHA, is an associate professor, Department of Pharmacotherapy and Translational Research; and Director, Precision Medicine Program – Gainesville Campus. She is also Director for the Graduate Program in Precision Medicine and the Associate Director, Center for Pharmacogenomics and Precision Medicine. Dr. Cooper-DeHoff’s area of research interest include coronary disease, dyslipidemias, hypertension and the factors that influence outcomes with cardiovascular pharmacotherapies. She also interest in the area of antihypertensive drug use and adverse metabolic effects including diabetes. In total, she has over 170 publications and many have been of high impact, helping to define demographic, clinical, metabolic, metabolomic and genetic and pharmacogenetic factors associated with responses to antihypertensive drugs and cardiovascular outcomes with antihypertensive therapy.